SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,322 | -54.1% | 111,900 | -7.6% | 0.00% | -100.0% |
| Q2 2023 | $580,112 | -10.1% | 121,109 | +6.5% | 0.00% | 0.0% |
| Q1 2023 | $645,008 | +0.7% | 113,758 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $640,282 | -11.8% | 114,336 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $726,000 | +152.1% | 113,150 | +34.8% | 0.00% | – |
| Q2 2022 | $288,000 | -54.1% | 83,944 | -4.9% | 0.00% | -100.0% |
| Q1 2022 | $628,000 | -21.5% | 88,234 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $800,000 | +22.3% | 96,007 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $654,000 | -71.4% | 94,000 | -2.0% | 0.00% | -66.7% |
| Q2 2021 | $2,289,000 | +33.5% | 95,966 | +15.2% | 0.00% | +50.0% |
| Q1 2021 | $1,715,000 | -16.2% | 83,283 | -0.3% | 0.00% | -33.3% |
| Q4 2020 | $2,047,000 | -10.0% | 83,534 | +4.0% | 0.00% | -25.0% |
| Q3 2020 | $2,275,000 | +622.2% | 80,349 | +21.3% | 0.00% | +300.0% |
| Q2 2020 | $315,000 | +53.7% | 66,253 | +15.2% | 0.00% | – |
| Q1 2020 | $205,000 | +4.6% | 57,493 | +1.1% | 0.00% | – |
| Q4 2019 | $196,000 | -14.0% | 56,844 | 0.0% | 0.00% | – |
| Q3 2019 | $228,000 | +115.1% | 56,844 | +72.3% | 0.00% | – |
| Q2 2019 | $106,000 | -53.3% | 32,982 | 0.0% | 0.00% | – |
| Q1 2019 | $227,000 | +52.3% | 32,982 | 0.0% | 0.00% | – |
| Q4 2018 | $149,000 | -37.9% | 32,982 | +4.3% | 0.00% | – |
| Q3 2018 | $240,000 | -11.8% | 31,612 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $272,000 | +17.2% | 31,612 | 0.0% | 0.00% | – |
| Q1 2018 | $232,000 | -29.7% | 31,612 | -3.0% | 0.00% | -100.0% |
| Q4 2017 | $330,000 | -36.9% | 32,581 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $523,000 | +27.6% | 32,581 | -10.2% | 0.00% | 0.0% |
| Q2 2017 | $410,000 | +1.5% | 36,280 | +1.1% | 0.00% | 0.0% |
| Q1 2017 | $404,000 | +11.3% | 35,880 | -2.2% | 0.00% | 0.0% |
| Q4 2016 | $363,000 | -21.6% | 36,680 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $463,000 | -57.4% | 37,680 | +0.8% | 0.00% | -50.0% |
| Q2 2016 | $1,086,000 | +125.3% | 37,380 | +106.0% | 0.00% | +100.0% |
| Q1 2016 | $482,000 | -13.8% | 18,147 | +14.0% | 0.00% | 0.0% |
| Q4 2015 | $559,000 | +21.0% | 15,919 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $462,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |